SANTA CLARA, Calif., September 13, 2021 /PRNewswire/ — The COVID-19 outbreak has inflated demand for smart, digitally connected medical devices, such as artificial intelligence (AI)-based mobile medical apps and medical imaging software, ensuring better management of serious respiratory illnesses. Innovative medical devices such as mobile medical apps and inhalers are the mainstay of the respiratory disease management industry. However, high device costs, high competition, lack of real-time feedback, and lack of patient awareness have limited the adoption of these technologies.
For more information on this analysis, Respiratory Health Management Technology Growth Opportunities, please visit: http://frost.ly/6b2
“The respiratory health market is focused on technological convergence, the integration of digital technologies and sensors to create smart, wearable and connected medical devices, and improving clinical outcomes and patient engagement during the disease management process,” said Ashish KaoulSenior Research Analyst, TechVision, at Frost & Sullivan.
Kaul added, “Mobile medical apps for diagnosing and managing respiratory diseases can reduce the cost of medical care by eliminating the need for regular medical tests. Additionally, smart medical devices such as inhalers that deliver personalized information and care anywhere are expected to increase adoption of a home disease management regimen within one to two years, as it follows the current trend of remote care.”
As mobile medical applications, oxygen concentrators, and smart inhalers are witnessing significant innovations fueled by the COVID-19 pandemic, market players can focus on the following to tap into these growth opportunities:
- Smart inhaler capable of providing feedback and support: Pharmaceutical companies can collaborate or partner with innovative start-ups that provide real-time feedback on inhalation technique and use acoustic technology for drug delivery to patients.
- Innovative and durable oxygen concentrators: Health technology companies and innovators can partner to explore opportunities to produce improved, durable, and easy-to-use oxygen concentrators for hospital and home use.
- Innovative mobile medical applications: Innovators should invest in research-based evidence to show the effectiveness of mobile medical apps in improving respiratory disease management.
Respiratory Health Management Technology Growth Opportunities is the latest addition to Frost & Sullivan’s Health care research and analysis available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous stream of growth opportunities to succeed in the unpredictable future.
About Frost & Sullivan
For six decades, Frost & Sullivan has been recognized globally for its role in helping investors, business leaders and governments navigate economic change and identify disruptive technologies, megatrends, new business models and companies into action, resulting in a continuous stream of growth opportunities. to drive future success. Contact us: Start the discussion.
Respiratory Health Management Technology Growth Opportunities
E: [email protected]
SOURCE Frost & Sullivan